Qualitative and quantitative assessments of HAART adherence of substance-abusing women

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 15, Issue 2, 2003, Pages 239-249

  Powell Cope, G M ^a   White, J ^b   Henkelman, E J ^c   Turner, Barbara J ^d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b Specialty Disease Management   (United States)

^c PRINCETON UNIVERSITY   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONFIDENTIALITY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; INTERVIEW; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SIDE EFFECT; SUBSTANCE ABUSE;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; FOCUS GROUPS; HIV INFECTIONS; HUMANS; PATIENT COMPLIANCE; PILOT PROJECTS; SUBSTANCE-RELATED DISORDERS;

EID: 0037391696     PISSN: 09540121     EISSN: None     Source Type: Journal    
DOI: 10.1080/0954012031000068380     Document Type: Article

References (40)

1. AJZEN, J. (1991). The theory of planned behavior. Organizational Behavior and Human Decision Processes, 50, 179-211.
2. AJZEN, I. & FISHBEIN, M. (1980). Understanding attitudes and predicting social behavior. Englewood Cliffs, NJ: Prentice Hall.
3. ARABE, J., RUBINI, N., RODRIGUES, A., LEAL, D., FREITAS, E., SION, F. & MORAIS DE-SA, C. (1998). Factors which influence adherence to the use of protease inhibitors. Proceedings of the International Conference on AIDS, 12, 602-603.
4. ARNSTEN, J., DEMAS, P., GOUREVITCH, M., BUONO, D., FARZADEGAN, H. & SCHOENBAUM, E. (2000). Adherence to chemotherapeutic regimens. Proceedings of the Seventh Conference on Retroviruses and Opportunistic Infection, 12, 69.
5. BANGSBERG, D., HECHT, F., CHARLEBOIS, E., ZOLOPA, A., HOLODNIY, M. & SHEINER, I. (2000). Adherence to protease inhibitors, HIV 1 vital load, and development of drug resistance in an indigent population. AIDS, 14, 357-366.
6. CARNEY, R., FREEDLAND, K., EISEN, S., RICH, M. & JAFFE, A. (1995). Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychology, 5, 88-90.
7. CATZ, S., KELLY, J., BOGART, L., BENOTSCH, E. & MCAULIFFE, T. (2000). Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychology, 19, 124-133.
8. CHESNEY, M. (1997). Compliance: how you can help. HIV Newsline, June, 67-72.
9. CHESNEY, M., ICKOVICS, J., CHAMBERS, D., GIFFORD, A., NEIDIG, J. & ZWICK, D. (2000). Self-reported adherence to antiretroviral medications among participants in an HIV clinical trial: the AACTG Adherence Instruments. AIDS Care, 12, 255-266.
10. DEMARCO, R.F., MULLER, K.H., PATSDAUGHTER, C.A., CHISHOLM, M. & GRINDEL, C.G. (1998). From silencing the self to action: experiences of women living with HIV/AIDS. Health Care for Women International, 19, 539-552.
11. DESCAMPS, D, FLANDRE, P. & CALVEZ, V. (2000). Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilege (Agence Nationale de Recherches sur le SIDA 072) Study Team). Journal of the American Medical Association, 283, 205-211.
12. DIMATTEO, M., LEPPER, H. & CROGHAN, T. (2000). Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Archives of Internal Medicine, 160, 2101-2107.
13. EYLER, F. & BEHNKE, M. (1995). Prenatal cocaine exposure: consequences for child and family. Journal of the Florida Medical Association, 82, 603-606.
14. GIFFORD, A., BORMANN, J., SHIVELY, M., WRIGHT, B., RICHMAN, D. & BOZZETTE, S. (2000). Predictors of self reported adherence and plasma HIV concentrations in patients on multi-drug antiretroviral regimens. Journal of Acquired Immunodeficiency Syndromes, 23, 386-395.
15. GORDILLO, V., DELAMO, J., SORIANO, V. & GONZALEZ-LAHOZ, J. (1999). Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS, 13, 1763-1769.
16. GRAY, J.J. (1999). The difficulties of women living with HIV infection. Journal of Psychosocial Nursing & Mental Health Services, 37, 39-43.
17. HADER, S.L., SMITH, D.K., MOORE, J.S. & HOLMBERG, S.D. (2001). HIV infection in women in the United States: status at the millennium. Journal of the American Medical Association, 285, 1186-1189.
18. HAUBRICH, R., LITTLE, S., CURRIER, J., FORTHAI, D., KEMPER, C., BEALL, G., JOHNSON, D., DUBE, M., HWANG, J. & MCCUTCHAN, J. (1999). The value of patient-reported adherence to antiretrovlral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group. AIDS, 13, 1099-1107.
19. ICKOVICS, J., HAMBURGER, M. & VLAHOV, D. (2001). Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV epidemiology research study. Journal of the American Medical Association, 285, 1466-1474.
20. JEMMOTT, L. & JEMMOTT, J. (1991). Applying the theory of reasoned action to AIDS risk behavior: condom use among black women. Nursing Research, 40, 228-234.
21. JUSTICE, A.C., HOLMES, W., GIFFORD, A.L., RABENEK, L., ZACKIN, R., SINCLAIR, G., WEISSMAN, S., NEIDIG, J., MARCUS, C., CHESNEY, M., COHN, S.E. & WU, A.W (2001). Development and validation of a self-completed HIV symptom index. Journal of Clinical Epidemiology, 54, Suppl 1, S77-90.
22. KOSKO, D., NEFF-SMITH, M. & KIM, M. (1998). Adherence barriers to complex antiretroviral regimen: the perceptions of HIV+ women and nurses. International Conference on AIDS, 12, 591-592.
23. MALDONADO, C., SANTIAGO, L., PACHECO, E., CORTES, I., HERRERA, D., MILAN, L. & HUERTAS, J. (1998). Depression in women living with HIV: high rates and decreasing trend. Proceedings of the International Conference on AIDS, 12, 436-437.
24. MARSH, J., D'AUNNO, T. & SMITH, B. (2000). Increasing access and providing social services to improve drug abuse treatment for women with children. Addiction, 95, 1237-1247.
25. MONTANER, H., HOGG, R., YIP, B., MONTESSORI, V., HEATH, K. & O'SHAUGHNESSY, M. (2000). Predictors of compliance with triple combination therapy among HIV-positive men and women in British Columbia. Proceedings of the International Conference on AIDS, Durban, S. Africa.
26. OHMIT, S., SCHUMAN, P. & SCHOENBAUM, E. (1998). Adherence to antiretroviral therapy (ART) among women in the HIV Epidemiology Research Study (HERS) and Women's Inter-Agency HIV Study (WIHS). Proceedings of the International Conference of AIDS, 12, 590.
27. PATERSON, D., SWINDELLS, S. & MOHR, J. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21-30.
28. PHIFER, N., MACLEAN, C.D., SCHULTZ, I.J. & SUSI, B.E. (2001). Racial differences in patients' attitudes about physicians' religious beliefs. 24th Annual Meeting of the Society of General Internal Medicine, San Diego abstract 102.
29. POPE, C. & MAYS, N. (1995). Reaching the parts other methods cannot reach: an introduction to qualitative methods in health and health services research. British Medical Journal, 311, 42-45.
30. ROBERTS, K. (2000). Barriers to and facilitators of HIV-positive patients' adherence to antiretroviral treatment regimens. AIDS Patient Care & STDS, 14, 155-168.
31. SAMBAMOORTHI, U., WALKUP, J., OLFSON, M. & CRYSTAL, S. (2000). Antidepressant treatment and health services utilization among HIV-infected Medicaid patients diagnosed with depression. Journal of General Internal Medicine, 15, 311-320.
32. SAMET, J., LIBMAN, H., STEGER, K., DHAWAN, R., CHEN, J., SHEVITZ, A., DEWEES-DUNK, R., LEVENSON, S., KUFE, D. & CRAVEN, D. (1992). Compliance with Zidovudine therapy in patients infected with human immunodeficiency virus, type 1: a cross-sectional study in a municipal hospital clinic. American Journal of Medicine, 92, 495-502.
33. SINGH, N., SQUIER, C., SIVEK, C., WAGENER, M., NGUYEN, M. & YU, V. (1996). Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS Care, 8, 261-269.
34. STEIN, M., URDANETA, M., CLARKE, J., MAKSAD, J., SOBOTA, M., HANNA, L. & MARKSON, L. (2000). Use of antiretroviral therapies by HIV-infected persons receiving methadone maintenance. Journal of Addictive Diseases, 19, 85-94.
35. STRATHDEE, S., PALEPU, A., CORNELISSE, P., YIP, B., O'SHAUGHNESSY, M., MONTANER, J.S., SCHECHTER, M. & HOGG, R. (1998). Barriers to use of free antiretroviral therapy in injection drug users. Journal of the American Medical Association, 280, 547-549.
36. TURNER, B.J., LAINE, C., ROTHMAN, J. & HAUCK, W.W. (2001). Gender differences in pharmacy based adherence to combination antiretroviral therapy and effect of health care delivery. 24th Annual Meeting of the Society of General Internal Medicine, San Diego abstract 100.
37. TURNER, B., NEWSCHAFFER, C., ZHANG, D., COSLER, L. & HAUCK, W. (2000). Antiretroviral use and pharmacy-based measurement of adherence in postpartum HIV-infected women. Medical Care, 38, 911-925.
38. VALDEZ, H., LEDERMAN, M., WOOLLEY, I., WALKER, C., VERNON, L., HISE, A. & GRIPSHOVER, B. (1999). Human immunodeficiency virus 1 protease inhibitors in clinical practice: predictors of virological outcome. Archives of Internal Medicine, 159, 1771-1776.
39. WELLS, E. (1997). Adherence to HIV treatments. HIV Frontline, 30, 1-3, 8.
40. WENGER, N., GIFFORD, A., LIU, H., CHESNEY, M., GOLIN, C., CRYSTAL, S., BERRY, S., COPLAN, P., BOZZETTE, S. & SHAPIRO, M. (1999). Patient characteristics and attitudes associated with antiretroviral (AR) adherence. Proceedings of the Conference on Retroviruses Opportunistic Infection, 6, 85.